Hot Features
Premium
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Zeitraum:
Zeichenmodus:
| Volumen | 0 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Keros Therapeutics Inc | KROS | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 45,65 | 10:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 45,65 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 27,02 - 73,00 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | US$ 45,65 | USD |
Finanzwerte KROS
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 1,65B | 36,08M | - | 151k | -152,99M | -4,24 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Keros Therapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 17.6.2024 | 23:17 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17.6.2024 | 23:15 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 17.6.2024 | 22:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17.6.2024 | 22:01 | GlobeNewswire Inc. | Keros Therapeutics Announces Leadership Updates |
| 17.6.2024 | 12:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17.6.2024 | 12:00 | GlobeNewswire Inc. | Keros Therapeutics Presents Clinical Data from its.. |
| 04.6.2024 | 14:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04.6.2024 | 14:00 | GlobeNewswire Inc. | Keros Therapeutics to Host a Corporate Update Conference.. |
| 03.6.2024 | 22:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 03.6.2024 | 22:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 03.6.2024 | 22:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 03.6.2024 | 14:01 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Keros Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
KROS Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 44,18 | 47,20 | 43,30 | 46,07 | 505.886 | 1,47 | 3,33% |
| 1 Monat | 47,35 | 51,36 | 43,30 | 47,10 | 394.207 | -1,70 | -3,59% |
| 3 Monate | 63,46 | 65,57 | 43,30 | 52,83 | 308.772 | -17,81 | -28,06% |
| 6 Monate | 38,62 | 73,00 | 37,72 | 55,82 | 383.445 | 7,03 | 18,20% |
| 1 Jahr | 41,19 | 73,00 | 27,02 | 47,18 | 310.124 | 4,46 | 10,83% |
| 3 Jahre | 45,00 | 73,00 | 24,38 | 45,48 | 231.522 | 0,65 | 1,44% |
| 5 Jahre | 20,10 | 88,80 | 20,10 | 47,25 | 202.948 | 25,55 | 127,11% |
